N+1 Singer restated their buy rating on shares of Sinclair Pharma PLC (LON:SPH) in a report released on Tuesday morning. N+1 Singer currently has a GBX 37 ($0.50) target price on the specialty pharmaceutical company’s stock.
A number of other research analysts have also recently issued reports on SPH. Peel Hunt restated a buy rating and set a GBX 68 ($0.92) price objective on shares of Sinclair Pharma PLC in a report on Monday, June 19th. Stifel Nicolaus restated a buy rating and set a GBX 71 ($0.96) price objective on shares of Sinclair Pharma PLC in a report on Tuesday, July 11th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Sinclair Pharma PLC presently has an average rating of Buy and a consensus price target of GBX 54 ($0.73).
Sinclair Pharma PLC (SPH) opened at 27.00 on Tuesday. The company has a 50-day moving average of GBX 29.00 and a 200-day moving average of GBX 31.10. Sinclair Pharma PLC has a 1-year low of GBX 26.00 and a 1-year high of GBX 36.35. The firm’s market cap is GBX 135.59 million.
WARNING: “Sinclair Pharma PLC (SPH) Receives Buy Rating from N+1 Singer” was originally published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://www.chaffeybreeze.com/2017/09/20/sinclair-pharma-plc-sph-receives-buy-rating-from-n1-singer.html.
About Sinclair Pharma PLC
Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor.
Receive News & Ratings for Sinclair Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinclair Pharma PLC and related companies with MarketBeat.com's FREE daily email newsletter.